Protide Pharmaceuticals (fka PPMD)

[Lazarus]

from the last Q:

The Company continues to sell its products on a direct basis to customers in the United States as well as to seventeen different countries around the world. In addition the Company has formed the following distribution avenues:

The Company has a nonexclusive worldwide distribution agreement with MP Biomedicals, Inc., Costa Mesa, CA. Under the agreement, MP Biomedicals is marketing Celox’ TCMTM, TCH™, TM-235™ serum replacement products as well as Cellvation™. MP Biomedicals manufactures and markets medical and biotechnology products worldwide.

In 1997, the Company began providing its proprietary products to Sigma Chemical Company (NASDAQ:SIAL), St. Louis, MO. under a private label distribution agreement for worldwide distribution.

The Company’s Celox product line is distributed in Japan through Funakoshi Co., LTD, a well-established Japanese distributor.

The Company also has distribution of its STEMSOLTM and DMSO/Dextran products in Europe and the Pacific Rim through various non-exclusive agreements with local distributors.